Prevention of Cardiovascular EventsEzator S.K. is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (CHD) and a history of acute coronary syndrome (ACS), either previously treated with a statin or not.
- HypercholesterolaemiaEzator S.K. is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate.
- patients not appropriately controlled with a statin alone.
- patients already treated with a statin and ezetimibe- Homozygous Familial Hypercholesterolaemia (HoFH)Ezator S.K. is indicated as adjunctive therapy to diet for use in adults with HoFH. Patients may also receive adjunctive treatments (e.g., low-density lipoprotein [LDL] apheresis).
